Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 11, 2011 - Issue 6
Submit an article Journal homepage
302
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

Cost–effectiveness of raltegravir in HIV/AIDS

Mohammad Ashraf Chaudhary Merck & Co., Inc., UG1C-60, 351 N. Sumneytown Pike, PO Box 1000, North Wales, PA 19454-2505, USA;[email protected]
,
Elamin H Elbasha Merck & Co., Inc., UG1C-60, 351 N. Sumneytown Pike, PO Box 1000, North Wales, PA 19454-2505, USA
,
Ritesh N Kumar Merck & Co., Inc.,WS2E-55, 1 Merck Drive, PO Box 100, Whitehouse Station, NJ 08889-0100, USA
&
Esther C Nathanson Watermeadow Medical USA, 349 Fifth Ave, 5th Floor, New York, NY 10016, USA
Pages 627-639 | Published online: 09 Jan 2014

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gilles Pialoux, Anne-Geneviève Marcelin, Hélène Cawston, Caroline Guilmet, Laurent Finkielsztejn, Audrey Laurisse & Céline Aubin. (2018) Cost-effectiveness of dolutegravir/abacavir/lamivudine in HIV-1 treatment-Naive (TN) patients in France. Expert Review of Pharmacoeconomics & Outcomes Research 18:1, pages 83-91.
Read now

Articles from other publishers (4)

Yu. Sh. Gushchina, А. Yu. Abramov & Y. J. Haitham. (2023) Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 16:2, pages 186-195.
Crossref
Anita J. Brogan, Ashley E. Davis & Bridgett Goodwin. (2018) Short-term cost analysis of raltegravir versus atazanavir + ritonavir or darunavir + ritonavir for treatment-naive adults with HIV-1 infection in the United States. PLOS ONE 13:8, pages e0203293.
Crossref
Nicolas Despiégel, Delphine Anger, Monique Martin, Neerav Monga, Qu Cui, Angela Rocchi, Sonia Pulgar, Kim Gilchrist & Rodrigo Refoios Camejo. (2015) Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada. Infectious Diseases and Therapy 4:3, pages 337-353.
Crossref
María Inés Figueroa, Omar Sued & Pedro Cahn. (2014) What to do Next? Second-line Antiretroviral Therapy. Current Treatment Options in Infectious Diseases 6:2, pages 159-170.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.